AUCTORES
Globalize your Research
Research | DOI: https://doi.org/10.31579/2693-2156/026
1 Resident of Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
2 Department of Nutrition, School of Health, Qazvin University of Medical Sciences, Qazvin, Iran.
3 Student Research Committee, School of Health, Qazvin University of Medical Sciences, Qazvin, Iran.
4 Ph.D. Candidate in Nutrition Research, Department of Nutrition Research, National Nutrition and Food Technology Research, Institute (NNFTRI), Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
5 Department of Biostatistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
6 Assistant Professor of Internal Medicine, Department of Internal Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
7 Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
8 Department of Nutrition, School of Allied Medical Science, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
*Corresponding Author: Narjes Zarei jalalabadi, Assistant Professor of Internal Medicine, Department of Internal Medicine, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Citation: Narjes Z. jalalabadi, Hamid Khederlou, Ahmadreza Rasouli, Razieh Anari, Fahime Moeini, et al. (2021). Evaluation of the Relationship between Serum Vitamin D and Morbidity and Mortality in Patients with COVID-19. J Thoracic Disease and Cardiothoracic Surgery, 2(3); DOI:10.31579/2693-2156/026
Copyright: © 2021, Narjes Zarei jalalabadi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 19 June 2021 | Accepted: 29 July 2021 | Published: 11 August 2021
Keywords: 2019 novel-coronavirus; calcidiol; COVID-19; prognosis; sars-cov; vitamin d; coronaviridae; Brazil; WHO; acute respiratory disease syndrome; thrombomodulin
Background: The COVID-19 can cause serious life-threatening complications. Vitamin D deficiency has been proposed to mediate the disease by some studies, however, there is a lack of sufficient data.
Methods: In this descriptive-analytical study, 72 Iranian adult patients with COVID-19 were examined. At the beginning of hospitalization, serum levels of vitamin D were checked and patients were divided into four groups as vitamin D above normal, normal, insufficient, or deficient. The prognosis of patients has been evaluated based on serum levels of vitamin D and other underlying factors.
Results: Only 30% of patients had normal vitamin D concentrations. Vitamin D status was associated with COVID-19 complications, but not with underlying diseases. In the multivariable logistic regression, COVID-19 prognosis was associated with being male, length of stay in an intensive care unit (ICU), need for intubation, acute respiratory disease syndrome (ARDS), and myocarditis. The serum vitamin D correlated with COVID-19 complications including ARDS, QT length, the requirement to ICU, and intubation.
Conclusion: This study showed a mediating role for vitamin D in COVID-19 complications and identified the frequent complications in these patients and contributing variables exaggerating prognosis for health authorities to properly manage COVID-19 in hospitals. Further relevant examinations are highly encouraged.
Coronaviruses are a type of RNA virus from the Coronaviridae (CoV) family that is widely distributed in mammals such as humans [1]. Family's CoV has caused severe acute respiratory distress syndrome (SARS-CoV) which started in 2002 and Middle East Respiratory Syndrome (MERS-CoV) which started in 2012 in more than 10,000 people [2, 3].
Since December 2019, the outbreak of viral pneumonia was observed in Wuhan, Hubei Province, China. After identifying the virus, the pathogen of this pneumonia was initially called the 2019 novel-coronavirus (2019-nCoV) [4]. The most common manifestations of 2019-nCoV are fever, nonproductive cough, myalgia, fatigue, weakness, diarrhea, dyspnea, anosmia, and hemoptysis [1]. Most people who become infected are asymptomatic and carrier, but it can cause serious side effects and life-threatening complications, including acute respiratory distress syndrome, pneumonia, myocarditis, acute kidney injury, and failure of other organs [5]. Respiratory failure is the most common dangerous complication of 2019-nCoV [6]. The most important risk factors for the 2019 coronavirus disease (COVID-19) progression are aging, immunodeficiency, and past underlying disease. Recent epidemiologic evidence suggested that vitamin D deficiency might be another potential risk factor for the disease [7].
Vitamin D is a fat-soluble vitamin produced in the skin after reaction of ultraviolet (UV) with 7-dehydrocholesterol and its biologically active form, 1,25-dihydroxy vitamin D, is finally made in the kidney [8]. Recent studies have shown that vitamin D, in addition to its role in bone mineralization and calcium transportation in the gut, has several receptors in the vascular endothelium, smooth muscle, and heart, as well as epithelium tissue of the airways, and it is effective in inflammatory processes [8-11]. Therefore, vitamin D is probably effective in the progression and severity of inflammatory and infectious diseases. However, there is scarce evidence regarding the impact of vitamin D status on COVID-19 incidence and mortality. Ecological studies from European countries supposed an inverse association between vitamin D status and COVID-19 incidence and mortality [12, 13]. However, observation of high mortality rates from COVID-19 in sunny countries like Brazil with relatively lower vitamin D deficiency (28%) is debatable [14].
Due to the high prevalence of 2019-nCoV, WHO declared the disease as a pandemic situation in 2020, and also its significant morbidity and mortality have imposed a huge cost on the health care system of many countries; therefore, identification of the most important risk factors engaged in initiation and treatment of this disease can be of great help to the health of individuals and societies. Therefore, this study was conducted to investigate the relationship between serum vitamin D levels and other mediating factors and COVID prognosis among patients with 2019-nCoV.
Study design: This was a hospital-based descriptive-analytical study. The study design was reviewed and approved by the Ethics Committee of Tehran University of Medical Sciences (Ethics code: IR.TUMS.VCR.REC.1399.421; 27 May 2020).
Subjects: After obtaining patients’ compliance through written consents, 72 adult patients with the 2019-nCoV diagnosis were subsequently recruited from Imam Khomeini hospital, one of the central hospitals for corona cases in Tehran metropolitan, Iran. Data was collected between 20 July 2020 and 27 August 2020.
2019-nCoV diagnosis: Suspected patients having complications like nonproductive cough, fever, dyspnea, and diarrhea were confirmed to have 2019-nCoV infection using RT-PCR and Chest CT scan tests. Patients with negative CT results were excluded from the study.
A checklist, including demographic data and disease history (having any underlying disease), was fulfilled for each patient. Venous blood samples were drawn after admission and were sent to the hospital’s laboratory to assess the serum concentration of vitamin D (Calcidiol). Immunoassay technique via liquid chromatography-tandem mass spectrometry (LC-MS/MS) was utilized to measure serum vitamin D and patients were divided into four groups based on their serum vitamin D concentrations: above normal (>50 ng/mL), normal (30-50 ng/mL), insufficient (10-29 ng/mL), and vitamin D deficiency (<10>
Finally, the obtained data were entered into SPSS software (version 25.0, IBM, NY, USA) and the relationship between serum levels of vitamin D and other relevant data for the prognosis of the studied patients was analyzed using descriptive statistical methods as well as logistic regression method. At all statistical stages, a significance level of 0.05 was the criterion for statistical judgments.
In this study, 72 patients with Covid-19 were examined. The mean age of patients was 56.69 years old (Minimum: 28, Maximum: 85 years) and 63.9% were male. (Table 1) presents the main characteristics of the studied population in detail.
| Variable | Value (n=72) | p-value |
Sex Female Male |
26 (36.1%) 46 (63.9%) | 0.634 |
Underlying disease No Yes |
10 (13.9%) 62 (86.1%) | 0.508 |
Type of underlying disease No Heart Disease Non- Heart Disease Both Heart and Non- Heart Disease |
9 (12.5%) 17 (23.6%) 26 (36.1%) 20 (27.8%) | 0.489 |
Needing to ICU No Yes |
52 (72.2%) 20 (27.8%) | 0.001* |
Needing to FIO2 No Yes |
22 (30.6%) 50 (69.4%) | 0.041* |
Needing to Intubation No Yes |
66 (91.7%) 6 (8.3%) | <0> |
Having Complication No Yes |
41 (56.9%) 31 (43.1) | 0.018* |
Pneumonia No Yes |
59 (81.9%) 13 (18.1%) | 0.710 |
ARDS No Yes |
65 (90.3%) 7 (9.7%) | 0.005* |
Sepsis No Yes |
65 (90.3%) 7 (9.7%) | 0.499 |
AKI No Yes |
60 (83.3%) 12 (16.7%) | 0.645 |
Myocarditis No Yes |
70 (97.2%) 2 (2.8%) | 0.005* |
DVT No Yes |
71 (98.6%) 1 (1.4%) | 0.807 |
Seizures No Yes |
71 (98.6%) 1 (1.4%) | 0.807 |
Complications of QT No Yes |
70 (97.2%) 2 (2.8%) | 0.728 |
MI No Yes |
71 (98.6%) 1 (1.4%) | <0> |
Vitamin D Status Deficient Insufficient Normal Above normal |
4 (5.6%) 40 (55.6%) 22 (30.6%) 6 (8.3%) | 0.046* |
| Age (year) | 56.69±15.13 | 0.003* |
| Serum vitamin D (ng/mL) | 27.05± 13.30 | 0.031* |
| Length of hospitalization (day) | 8.56± 6.08 | 0.079 |
| Length of stay in ICU (day) | 2.18±4.67 | < 0> |
FIO2: Fraction of Inspired Oxygen, ARDS: Acute Respiratory Disease Syndrome, AKI: Acute Kidney Injury, DVT: Deep Vein Thrombosis, MI: Myocardial Infarction.
P<0>
Table 1: Characteristics of studied patients and their relation to the final prognosis.
Mean serum vitamin D was 27.05 ng/mL (SD: 13.30) and only one-third of participants had normal serum vitamin D. In this study participants 68 patients (94.4%) were discharged and 4 patients (5.6%) died. The most prevalent complication among these patients was Pneumonia (14.9%) and AKI (13.8%). Median and Mean of serum vitamin D concentration at recruitment was lower in patients who subsequently finally dead from COVID-19 infection than discharged participants (14.50 vs. 24.65, Mean: 14.75 vs. 27.05 ng/mL; p=0.040).
COVID-19 prognosis was predicted univariably (OR = 2.78, 95% CI: 0.51-15.26, p = 0.24), and after adjustment for covariates, including age, sex, length of hospitalization (day), requirement to ICU, length of stay in ICU (day), requirement to FIO2, requirement to intubation, and having a complication (Binary logistic regression, Forward manner). Exposures that predicted COVID-19 prognosis in the multivariable logistic regression were male sex (OR=1.21; 95% CI=1.01-1.45; p-value=0.039), length of stay in ICU (day)(OR= 1.23; 95% CI =1.05-1.43; p-value=0.011), need to intubation (OR=7.07; 95% CI=5.12-82.58; p-value=0.052), ARDS (OR=9.31; 95% CI=0.922-94.05; p-value=0.059), and myocarditis (OR=8.02; 95% CI = 1.11-45.01; p-value = 0.027) (Table 2).
| Variable | r | p-value |
| Age (year) | 0.34 | 0.004* |
| Sex | 0.27 | 0.164 |
| Length of hospitalization (day) | 0.56 | 0.189 |
| Length of stay in ICU (day) | 0.51 | 0.058 |
| Underlying disease | 0.15 | 0.672 |
| Type of underlying disease | 0.41 | 0.197 |
| Needing to ICU | 0.37 | 0.021* |
| Needing to FIO2 | 0.42 | 0.005* |
| Needing to Intubation | 0.23 | 0.282 |
| Having a Complication | 0.31 | 0.070 |
| Pneumonia | 0.16 | 0.600 |
| ARDS | 0.35 | 0.033* |
| Sepsis | 0.31 | 0.073 |
| AKI | 0.17 | 0.549 |
| Myocarditis | 0.15 | 0.649 |
| DVT | 0.11 | 0.847 |
| Seizures | 0.11 | 0.847 |
| Complications of QT | 0.35 | 0.031* |
| MI | 0.11 | 0.847 |
FIO2: Fraction of Inspired Oxygen, ARDS: Acute Respiratory Disease Syndrome, AKI: Acute Kidney Injury, DVT: Deep Vein Thrombosis, MI: Myocardial Infarction.
Phi, Cramer's V, Contingency Coefficient, Kendall's tau-b, Kendall's tau-c, Spearman Correlation, Pearson‘s Correlation tests were used for analysis. P<0.05 was significant.
Table 2: Correlation between serum vitamin D and demographic and clinical variables.
When participants were categorized into vitamin D deficiency (<10>50 ng/mL), the pattern of results was similar to those observed with serum levels of vitamin D entered numerically and as a continuous variable (univariable OR =2.78, 95% CI= 0.51-15.26, p = 0.24; adjusted p =0.95).
As Table 2 demonstrates, serum vitamin D was an only correlation with ARDS, QT length, the requirement to ICU, and intubation.
The widespread of the novel COVID around the world and a great deal of hospitalization with numerous culprits raised concerns to distinguish the underlying contributing factors, especially those affecting the severity and prognosis of the disease. Due to the infectious nature of the disease, identification of the underlying factors mediating the immunity response was the core of many investigations. Some studies have proposed that low circulatory vitamin D has been correlated to SARS-CoV-2 infection susceptibility and severity [16,17]. For example, a recent cohort in Switzerland on elderly patients demonstrated a lower serum vitamin D in PCR-positive cases over 70 years old [16]. Vitamin D deficiency has been suggested as a COVID-19 mediator because of its significant role in innate immune regulation [18,19], its modulatory effects on inflammatory responses to infections, and the existence of several vitamin D receptors in different tissues and organs from airways to the heart, especially in leucocytes [8-11,20]. vitamin D also counteracts tumor necrosis factor (TNF), Low-density lipoprotein (LDL), and other inflammatory mediators by reducing the expression of CD40 in inflammatory cells, down-regulation of tissue factor, and up-regulation of thrombomodulin in monocyte cells [21].
Although some reviews have proposed some mediating roles for vitamin D in COVID-19 morbidity [18, 19], there is a lack of sufficient clinical data regarding the association of serum vitamin D with COVID-19 prognosis. A small study in the US reported that patients admitted to ICU had probably higher vitamin D deficiency compared to those admitted to medical wards (84.6% versus 57.1%) (22). According to our results, poor vitamin D status was associated highly with the length of stay in ICU and after that with ICU admission, needing to FIO2, ARDS, and QT length, but not with death prognosis. Therefore, vitamin D status may indirectly contribute to prognosis in association with ARDS, QT length, and the requirement to ICU and intubation.
The current investigation demonstrated that COVID prognosis was strongly correlated to being male, ARDS, myocarditis, ICU requirement, need to intubation and length of stay in ICU, and Pneumonia (14.9%) and AKI (13.8%) were the most prevalent complications in our studied patients. These results were in accordance with previous findings implying that COVID-19 was mostly accompanied by pneumonia, ARDS leading to ICU admission, and multi-organ failure [23]. Previous studies proposed age as a contributing factor in COVID mortality [7], we also observed that older patients had 24% higher COVID-19 prognosis. Also, we observed that female had better COVID prognosis, this could be due to lower ACE2 expression in males than in females which influence the susceptibility to death from COVID-19 [24]. As our results showed, ARDS was a prevalent complication in COVID patients. A meta-analysis of 25 trials revealed that vitamin D supplementation could reduce the risk of acute respiratory infections in all patients, but mostly in those with serum vitamin D <50> in our subjects.
The current study had several strengths. It was the first study that assessed the association between vitamin D status and COVID-19 prognosis, specifically in Iran, a country with rather high vitamin D deficiency and moderate COVID victims. Predicting the COVID-19 prognosis in hospitalized patients using some clinical data was another achievement of this study. Also, the investigation clarified the strongly correlated factors to COVID prognosis, i.e. age, ARDS, myocarditis, MI, intensive care requirement, and length of stay in ICU in the studied population.
This study faced some limitations. Due to the cross-sectional design of this investigation, we could not distinguish the cause-effect relationship between vitamin D status and disease initiation. Also, some health conditions and drugs may affect both vitamin D status and disease severity. Lack of anthropometric and inflammatory measures were other limitations. These factors restrict the generalization of our findings.
To conclude, based on our results, vitamin D participates in COVID-19 complications and possibly in its prognosis. Awareness of the frequent complications in patients having COVID in addition to predicting variables could help health professionals and authorities to consider the proper facilities and the best approaches to manage COVID-19 in hospitals. Further examinations with greater sample size, longer duration, and inclusion of other mediating conditions, like anthropometric measures and inflammatory factors, is highly recommended.
Ethics approval and consent to participate
This study was licensed by the Ethical Committee of Tehran University of Medical Sciences with the code of IR.TUMS.VCR.REC.1399.421.
Consent for publication
Not applicable
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
Competing interests
The authors declare that there is no conflict of interest.
Funding
This research received no grant from any funding agency in the public, commercial, or not-for-profit sectors.
This study was licensed by the Ethical Committee of Tehran University of Medical Sciences with the code of IR.TUMS.VCR.REC.1399.421.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
